Jim Simons’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Jim Simons’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,400	Closed	-$222K	–	3817
2021 Q1	$222K	Buy	+4,400	New	+$235K	﹤0.01%	3123
2019 Q3	–	Sell	-7,400	Closed	-$295K	–	3756
2019 Q2	$295K	Buy	+7,400	New	+$291K	﹤0.01%	3180
2019 Q1	–	Sell	-8,600	Closed	-$315K	–	3743
2018 Q4	$315K	Buy	+8,600	New	+$367K	﹤0.01%	3013

Other funds holding XPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Jim Simons's XPH Position: Q2 2021 in Review

Jim Simons sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2021, closing a stake of 4,400 shares — an estimated $222K sold.

Jim Simons first reported a position in XPH in Q4 2018 and held it in 3 quarters. The position peaked at $315K in Q4 2018. 79 funds tracked by Wall St. Rank hold XPH as of Q2 2021.

Jim Simons reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
Jim Simons sold 4,400 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2021, an estimated $222K.
Jim Simons first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2018 and held it in 3 quarters.
Jim Simons's State Street SPDR S&P Pharmaceuticals ETF position peaked at $315K in Q4 2018.
79 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2021.

Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.